BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 23357213)

  • 1. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
    Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
    J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.
    Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ
    J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-week, prospective, open-label, randomized trial on the effects of an anticholinergic agent or antidiuretic agent as add-on therapy to an alpha-blocker for lower urinary tract symptoms.
    Shin YS; Zhang LT; Zhao C; Kim YG; Park JK
    Clin Interv Aging; 2014; 9():1021-30. PubMed ID: 25031529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.
    Lee SH; Chung BH; Kim SJ; Kim JH; Kim JC; Lee JY
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):320-5. PubMed ID: 21788967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP; Herschorn S; Albei CD; van der Meulen EA
    J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
    Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male patients with a higher frequency of nocturnal urinary episodes are more likely to benefit from alpha-blocker therapy for bothersome nocturia.
    Lee CL; Kuo HC
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O174-O179. PubMed ID: 30548822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK; Dmochowski RR; Reddy J; van der Meulen EA
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study.
    Wang CJ; Lin YN; Huang SW; Chang CH
    J Urol; 2011 Jan; 185(1):219-23. PubMed ID: 21074790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice.
    Chen SL; Huang YH; Hung TW; Ou YC
    Int J Clin Pract; 2016 May; 70(5):372-9. PubMed ID: 27039892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients - a network meta-analysis.
    Su YT; Chen HL; Teoh JY; Chan VW; Wu WJ; Lee HY
    BMC Urol; 2023 Oct; 23(1):154. PubMed ID: 37789333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia.
    Takahashi S; Tajima A; Matsushima H; Kawamura T; Tominaga T; Kitamura T
    Int J Urol; 2006 Jan; 13(1):15-20. PubMed ID: 16448426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early effect of dutasteride added to alpha-1 blocker therapy for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Araki K; Naya Y; Inahara M; Suzuki F; Ota S; Tsuji H; Mikami K; Yanagisawa M; Awa Y; Suzuki H
    Int J Urol; 2014 Aug; 21(8):815-9. PubMed ID: 24735081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of naftopidil on nocturia after failure of tamsulosin.
    Oh-oka H
    Urology; 2008 Nov; 72(5):1051-5. PubMed ID: 18817955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
    Berges R; Höfner K; Gedamke M; Oelke M
    World J Urol; 2014 Oct; 32(5):1163-70. PubMed ID: 25135845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction.
    Paick JS; Ku JH; Shin JW; Yang JH; Kim SW
    BJU Int; 2006 May; 97(5):1017-23. PubMed ID: 16643483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin for treating nocturia in men.
    Han J; Jung JH; Bakker CJ; Ebell MH; Dahm P
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012059. PubMed ID: 29055129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.